You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi ⊕

found 2026 › Mar › 18 (Wed) @ 17:43 UTC

FDA ■■
J ■■
Tremfya ■■
Skyrizi ■■
Johnson ■■
US Food ■■
Drug Administration ■■

Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.